Electrode-level compressibility may not imply transferable hardware redundancy in biomimetic myoelectric interfaces. This study tested whether sensor-count sufficiency discovered by trial-level analysis survives participant-grouped evaluation. Dataset A comprised 398 archived Myo Armband trials from eight gestures. Dataset B contained 864 one-second trials from 36 participants and six gestures. A timestamp audit identified extensive repeated channel values; Dataset B was therefore analyzed on a conservative 100 Hz grid with 20–45 Hz filtering. Sensor subsets and RBF-SVM parameters were selected exclusively within grouped training data using repeated nested validation. Electrode-level NMF, all 28 fixed six-sensor layouts, cyclic re-indexing, channel-block ablation, participant-cluster bootstrap, PCA, and time-domain-only sensitivity analyses were evaluated. Dataset A yielded 97.74% accuracy with six sensors and 97.93% with eight. In Dataset B, accuracy was 75.96% ± 7.47% with six sensors and 77.93% ± 6.49% with eight; the paired difference was −1.97 percentage points (corrected 95% CI, −5.50 to 1.56). The participant-cluster bootstrap interval was −3.70 to −0.31 points. Active-gesture accuracy was 71.67% and 74.35%, respectively. All fixed six-sensor layouts averaged 74.59%. Three NMF components reconstructed 89.95% ± 1.78% of held-out-participant normalized RMS patterns, with no nonconverged folds. One-position cyclic re-indexing reduced accuracy to 40.28%; channel-block ablation caused losses of 0.62–6.71 points. Low-dimensional electrode-level RMS structure did not establish removable sensors across unseen users. Compact biomimetic interfaces require registration, adaptation, or equivariant processing before physical sensor reduction.
No takes yet. Share an insight, caveat, or question.
İsmail Çalıkuşu (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: